These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization. Filipska I; Winiarska A; Knysak M; Stompór T Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33920096 [TBL] [Abstract][Full Text] [Related]
4. The Impact of CKD on Uremic Toxins and Gut Microbiota. Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343 [TBL] [Abstract][Full Text] [Related]
5. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine]. Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678 [TBL] [Abstract][Full Text] [Related]
7. Uremic Vascular Calcification: The Pathogenic Roles and Gastrointestinal Decontamination of Uremic Toxins. Chao CT; Lin SH Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33371477 [TBL] [Abstract][Full Text] [Related]
8. [Uremic toxins and gut micro biome]. Vaziri ND; Suematsu Y; Shimomura A; Vaziri ND Nihon Jinzo Gakkai Shi; 2017; 59(4):535-544. PubMed ID: 30620802 [TBL] [Abstract][Full Text] [Related]
9. Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease. Black AP; Cardozo LF; Mafra D Ther Apher Dial; 2015 Oct; 19(5):436-40. PubMed ID: 25944654 [TBL] [Abstract][Full Text] [Related]
10. Understanding and Therapeutic Strategies of Chinese Medicine on Gut-Derived Uremic Toxins in Chronic Kidney Disease. Guo C; Rao XR Chin J Integr Med; 2018 Jun; 24(6):403-405. PubMed ID: 29752692 [TBL] [Abstract][Full Text] [Related]
11. Link between gut microbiota dysbiosis and chronic kidney disease. Noce A; Marchetti M; Marrone G; Di Renzo L; Di Lauro M; Di Daniele F; Albanese M; Di Daniele N; De Lorenzo A Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):2057-2074. PubMed ID: 35363356 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach. Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122 [TBL] [Abstract][Full Text] [Related]
13. The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial. Ebrahim Z; Proost S; Tito RY; Raes J; Glorieux G; Moosa MR; Blaauw R Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215453 [TBL] [Abstract][Full Text] [Related]
14. Urea and impairment of the Gut-Kidney axis in Chronic Kidney Disease. Di Iorio BR; Marzocco S; Nardone L; Sirico M; De Simone E; Di Natale G; Di Micco L G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207222 [TBL] [Abstract][Full Text] [Related]
18. The impact of gut microbiota on kidney function and pathogenesis. Mahmoodpoor F; Rahbar Saadat Y; Barzegari A; Ardalan M; Zununi Vahed S Biomed Pharmacother; 2017 Sep; 93():412-419. PubMed ID: 28654798 [TBL] [Abstract][Full Text] [Related]
19. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids. Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376 [TBL] [Abstract][Full Text] [Related]
20. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease. Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]